Danielle Anderson
Family · Maple Grove, MNNPI 1629778014
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,447 of the $5,521 with a category attached, or 62.4%. 13 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 50.4% of the total. Reporting peaked in 2023 at $3,160 and has fallen 66.8% since, to $1,050 in 2025. Among family clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 68 payments — averaging $81.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$3K
- Boston Scientific$1K
- SPR Therapeutics, Inc$385
- Biotronik NRO, Inc.$334
- Curonix LLC$284
- Relievant Medsystems, Inc.$109
- plus $189 from 7 others
What the payments were for
- Travel & lodging$2,07338%
- Food & beverage$3,44762%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 14 | $2,782 |
| Boston Scientific | 27 | $1,439 |
| SPR Therapeutics, Inc | 4 | $385 |
| Biotronik NRO, Inc. | 7 | $334 |
| Curonix LLC | 4 | $284 |
| Relievant Medsystems, Inc. | 2 | $109 |
| Medtronic | 2 | $73 |
| Vertos Medical, Inc. | 3 | $44 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Nevro Corp. | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| AbbVie | 1 | $15 |
| Biocomposites Inc | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,521 in reported general payments places this provider in the 95th percentile of 1,121 family providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 61 | $40,593 |
| Buprenorphine | 36 | $10,013 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 16 | $5,075 |
| OxycontinOxycodone Hcl | 17 | $4,815 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 129 | $3,321 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 161 | $2,717 |
| Oxycodone Hcl | 148 | $2,211 |
| Gabapentin | 112 | $1,727 |
| Morphine Sulfate ErMorphine Sulfate | 91 | $1,704 |
| Pregabalin | 74 | $1,252 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $1,082 |
| Naloxone Hcl | 12 | $816 |
| Tizanidine Hcl | 77 | $753 |
| Cyclobenzaprine Hcl | 36 | $721 |
| Diclofenac Sodium | 22 | $370 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $16 | $40,59361 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,121 family providers in Minnesota.
Other family in Maple Grove
- Alyssa GoodewMaple Grove$18K
- Stacy WoodardMaple Grove$7K
- Erin HewittMinnetonka$172K
- Julia GourdeMinneapolis$65K
- Robin DontaMinneapolis$60K
- Kristin WeberMinneapolis$35K
- Crista WenischBurnsville$30K
- Kathleen FredellMinneapolis$28K
- Christina RichardsonNorthfield$27K
- Diana CzelMinneapolis$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.